Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
about
N-terminal fragment of B-type natriuretic peptide (NT-proBNP), a marker of cardiac safety during antipsychotic treatmentMolecular and cellular mechanisms of cardiotoxicity.Cardiopulmonary laboratory biomarkers in the evaluation of acute dyspneaHeart failure in patients with chronic kidney disease: a systematic integrative reviewNatriuretic Peptides and Cardiometabolic HealthNatriuretic peptides as biomarkers in heart failureObesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failureCan biomarkers help to diagnose early heart failure with preserved ejection fraction?Symptom burden, Metabolic profile, Ultrasound findings, Rhythm, neurohormonal activation, haemodynamics and health-related quality of life in patients with atrial Fibrillation (SMURF): a protocol for an observational study with a randomised intervenShort-Term Influence of Radiofrequency Ablation on NT-proBNP, MR-proANP, Copeptin, and MR-proADM in Patients With Atrial Fibrillation: Data From the Observational SMURF StudyANP, BNP, and CNP enhance bradycardic responses to cardiopulmonary chemoreceptor activation in conscious sheep.Increased plasma levels of natriuretic peptide type B and A in children with congenital heart defects with left compared with right ventricular volume overload or pressure overload.Brain natriuretic peptide assessed at long-term follow-up before and after maximal exercise in surgically palliated patients with functionally univentricular hearts.Increased natriuretic peptide type B level after the second palliative step in children with univentricular hearts with right ventricular morphology but not left ventricular morphology.Plasma brain natriuretic peptide as a surrogate marker for cardioembolic strokeTranscriptome profiling of peripheral blood cells identifies potential biomarkers for doxorubicin cardiotoxicity in a rat modelManifold implications of obesity in ischemic heart disease among Japanese patients according to covariance structure analysis: Low reactivity of B-type natriuretic peptide as an intervening risk factor.High Plasma Levels of the B-type Natriuretic Peptide in Patients Without Heart Failure: Is There Clinical Significance?Hyponatraemia in a neurosurgical patient: syndrome of inappropriate antidiuretic hormone secretion versus cerebral salt wasting.Serum aldosterone and death, end-stage renal disease, and cardiovascular events in blacks and whites: findings from the Chronic Renal Insufficiency Cohort (CRIC) StudyTowards a blood test for heart failure: the potential use of circulating natriuretic peptides.Ventilatory expired gas at constant-rate low-intensity exercise predicts adverse events and is related to neurohormonal markers in patients with heart failureNatriuretic peptides in the pathophysiology of congestive heart failure.Biomarkers in predicting mortality and treatment in hemodialysis patientsPlasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.Triiodothyronine and brain natriuretic peptide: similar long-term prognostic values for chronic heart failure.B-type natriuretic peptide: the level and the drug--partners in the diagnosis of congestive heart failure.Regulation of apoptosis by vasoactive peptides.Relation of natriuretic peptides and midregional proadrenomedullin to cardiac chamber volumes by computed tomography in patients without heart failure: from the ROMICAT TrialThe plasma B-type natriuretic peptide levels are low in males with stable ischemic heart disease (IHD) compared to those observed in patients with non-IHD: a retrospective studyHeart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.Neprilysin Inhibition in Heart Failure with Reduced Ejection Fraction: A Clinical Review.Associations of N-terminal pro-B-type natriuretic peptide with kidney function decline in persons without clinical heart failure in the Heart and Soul StudyEffect of valsartan on N-terminal pro-brain natriuretic Peptide in patient with stable chronic heart failure: comparison with enalaprilN-terminal-pro-brain natriuretic peptide is decreased in insulin dependent gestational diabetes mellitus: a prospective cohort trial."BNP" for heart failure: role of nesiritide in cardiovascular therapeutics.B-type natriuretic peptides for the prediction of cardiovascular events in patients with stable coronary heart disease: the Heart and Soul Study.NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.Nesiritide: a novel approach for acute heart failure.Specific antioxidant selenoproteins are induced in the heart during hypertrophy
P2860
Q24804676-4CB43628-91C5-44FC-B879-B76F41CC3DBCQ24814079-EE770A6C-7D59-43CF-9F0B-BA06AF75B6D8Q26745756-3C5E659A-2C40-435D-B744-23E8F9D2B23CQ26824149-55FFC8D9-BCB9-411E-AABC-5FA64F182087Q26827702-9171EA91-0A8C-49E1-B20A-0A2E8C6113A9Q27012872-2EACFBEC-C0A0-4217-84ED-875DFDA747B0Q27027081-FE175D33-C736-41F9-9017-BE934AAC2D4DQ28087822-E03B71FD-865A-46CF-B1CD-2A3A524ACCC8Q30395217-2354D83A-767C-4099-940B-EA3CB17E5097Q31131029-01BD155F-2B4A-49E4-8E5A-E69E91CA43F9Q31733376-B1FB4A7D-B7B7-4CEF-A8EB-F701833ADA22Q33222138-A1F3FF7B-0023-401F-9EE5-E8049E9035BEQ33288659-E8FC0C33-D25C-498A-AD58-376D45C17C97Q33321591-44E9C2C4-BA6C-4A67-93BF-557F00D42AEFQ33392414-216CE451-1C80-4BFA-9861-71D72A76B664Q33404672-B0323A47-358D-4F47-9C8A-A4F26D90E62AQ33648242-154F2FAD-FC96-422A-8B92-D82F00520648Q33751298-63A089E6-A4A9-4A93-9438-29697F1E0A30Q33825124-FB051CF4-8C03-4C27-A0BA-6E61CA903E8BQ33871492-411A0E52-E188-4F42-BD9B-11685CFD88AAQ33962030-71510602-AC07-46C5-B75B-B21A4181CE24Q34003681-C1C77E85-B680-4A16-9B65-111EAFE9F617Q34027488-7F499EBA-5CB0-43EA-AAB5-893DFB4B3813Q34062442-ED2543EC-CDBC-4DD0-AE70-612F1ADC83AAQ34159897-BF8ADBA4-26F5-4AC0-8F84-6228D24DBC90Q34190826-96D8F358-DACC-4C9E-9049-796165893034Q34297057-72A7CB0B-A80C-4CBF-BAB4-2CC6B67ADDE8Q34369962-2C112BC2-34A2-4E88-A2F7-71F0FCF07941Q34381858-A7B51784-9D3F-4EB2-B1CA-B4DBFDF7B147Q34433995-9AD44364-5C4D-411E-A339-1AB58A35C64DQ34448373-FA216134-09EA-4AEC-B0DE-B8710A0AEEC5Q34495751-955A996D-090E-4DFF-A672-81CAC8A57241Q34625940-F1102C52-061F-432D-8966-56B02FFFAB2AQ34648756-6B8E56EC-EA41-4D14-8BA7-118D33065288Q34871241-0B190FDB-F2BF-4D87-ACE0-21D00BADC968Q34943458-3889B4E4-ADE8-44F3-9ACB-FDB834CA3E10Q35026256-C8F9CDDE-8F92-408C-AD93-3F8D3C65C243Q35051193-B49148D6-9304-49E7-A197-1066DF11EDC0Q35054263-7C1D5319-3C99-48AA-B897-688288FF1CC8Q35085592-07B5EEE7-E6D1-436E-9226-A5CE925A8192
P2860
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Localization and mechanism of ...... d patients with heart failure.
@en
Localization and mechanism of ...... d patients with heart failure.
@nl
type
label
Localization and mechanism of ...... d patients with heart failure.
@en
Localization and mechanism of ...... d patients with heart failure.
@nl
prefLabel
Localization and mechanism of ...... d patients with heart failure.
@en
Localization and mechanism of ...... d patients with heart failure.
@nl
P2093
P356
P1433
P1476
Localization and mechanism of ...... d patients with heart failure.
@en
P2093
Jougasaki M
Kugiyama K
Mukoyama M
Yoshimura M
P304
P356
10.1161/01.CIR.90.1.195
P407
P577
1994-07-01T00:00:00Z